Current Effective Therapeutics in Management of COVID‐19

32Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

Abstract

The current pandemic due to the SARS‐CoV‐2 virus has caused irreparable damage glob-ally. High importance is placed on defining current therapeutics for Coronavirus Disease 2019 (COVID‐19). In this review, we discuss the evidence from pivotal trials that led to the approval of effective therapeutics in the treatment and prevention of COVID‐19. We categorize them as effective outpatient and inpatient management strategies The review also attempts to contextualize the efficacy of therapeutics to the emerging variants. Vaccines, which remain the most effective prevention against hospitalization and deaths is not included in this review.

Cite

CITATION STYLE

APA

Atluri, K., Aimlin, I., & Arora, S. (2022, July 1). Current Effective Therapeutics in Management of COVID‐19. Journal of Clinical Medicine. MDPI. https://doi.org/10.3390/jcm11133838

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free